United States Second Circuit

In an action to compel the FDA to finalize its regulation of triclosan and triclocarban, two chemicals used in over-the-counter antiseptic antimicrobial soap, summary judgment to defendants is vacated where: 1) plaintiff has presented evidence of Article III standing sufficient to withstand summary judgment as to the regulation of triclosan; but 2) plaintiff presented insufficient evidence of members’ direct exposure to triclocarban to support standing.

Appellate Information

• Decided 03/15/2013
• Published 03/15/2013

Judges

• POOLER

Court

• United States Second Circuit

Counsel